New self-reported data published in the Journal of Psychopharmacology reveals patients who have access to medical marijuana decrease their use of opioids, anti-depressants, anti-anxiety drugs, and other medications. Investigators out of five states looked at the medical history of 1,500 patient-members of state-licensed dispensaries in the northeast and found 77% of respondents reduced their use of opioids after beginning cannabis therapy. Many respondents also decreased their use of anti-anxiety medications (72%), migraine-related medications (67%), sleep aids (65%), and anti-depressants (38%). Additionally, 42% of respondents reduced their use of alcohol. The findings of this study support the findings of previous studies regarding the effects of cannabis on opioids and other prescription medications.
This information has been provided by the Daily Chronic and approved by our Chief Medical Officer.